Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where O. V. Sudheer is active.

Publication


Featured researches published by O. V. Sudheer.


Indian Journal of Gastroenterology | 2015

Acute liver failure due to zinc phosphide containing rodenticide poisoning: Clinical features and prognostic indicators of need for liver transplantation

Vivek Saraf; Supriya Pande; Unnikrishnan Gopalakrishnan; Dinesh Balakrishnan; O. V. Sudheer; Puneet Dhar; S. Sudhindran

Zinc phosphide (ZnP) containing rodenticide poisoning is a recognized cause of acute liver failure (ALF) in India. When standard conservative measures fail, the sole option is liver transplantation. Records of 41 patients admitted to a single centre with ZnP-induced ALF were reviewed to identify prognostic indicators for requirement of liver transplantation. Patients were analyzed in two groups: group I (n = 22) consisted of patients who either underwent a liver transplant (n = 14) or died without a transplant (n = 8); group II (n = 19) comprised those who survived without liver transplantation. International normalized ratio (INR) in group I was 9 compared to 3 in group II (p < 0.001). Encephalopathy occurred only in group I. Model for End-Stage Liver Disease (MELD) score in group I was 41 compared to 24 in group II (p < 0.001). MELD score of 36 (sensitivity of 86.7 %, specificity of 90 %) or a combination of INR of 6 and encephalopathy (sensitivity of 100 %, specificity of 83 %) were the best indicators of mortality. Such patients should undergo urgent liver transplantation.


Liver Transplantation | 2016

Perioperative prostaglandin e1 infusion in living donor liver transplantation: A double‐blind, placebo‐controlled randomized trial

Viju Kumar Bharathan; Biju Chandran; Unnikrishnan Gopalakrishnan; Christi Titus Varghese; Dinesh Balakrishnan; O. V. Sudheer; Puneet Dhar; Sudhindran Surendran

The role of prostaglandin E1 (PGE1) infusion in improving early graft function has not been well defined, especially in the scenario of living donor liver transplantation (LDLT). We designed a randomized, double‐blind, placebo‐controlled trial to evaluate the role of perioperative PGE1 infusion in LDLT. Patients in the study arm received PGE1 (alprostadil) at the rate of 0.25 μg/kg/hour, starting at 1 hour after portal venous reperfusion, and continued for 96 hours. The primary endpoint was early allograft dysfunction (EAD). We analyzed multiple secondary endpoints including postoperative liver function and renal function parameters, acute kidney injury (AKI), hepatic artery thrombosis (HAT), postoperative bleeding, overall mortality, and posttransplant hospital stay. The incidence of EAD was lower in the PGE1 arm, although the difference did not reach statistical significance (22.4% versus 36%; P = 0.21). Among the secondary endpoints, the incidence of AKI was significantly lower in the PGE1 arm (8.2% versus 28%; P = 0.02), as were the peak and mean postoperative creatinine levels. The need for renal replacement therapy was similar between the 2 groups. Among the postoperative graft function parameters, postoperative alanine aminotransferase level was significantly lower in the PGE1 arm (P = 0.04), whereas the remaining parameters including serum bilirubin, aspartate aminotransferase, and international normalized ratio were similar between the 2 arms. There was no difference in the incidence of HAT and postoperative bleeding, in‐hospital mortality, and posttransplant hospital stay between the 2 arms. Perioperative PGE1 infusion reduces the incidence of posttransplant renal dysfunction in patients undergoing LDLT. Liver Transplantation 22 1067–1074 2016 AASLD


Liver Transplantation | 2018

Randomized trial on extended versus modified right lobe grafts in living donor liver transplantation

Christi Titus Varghese; Viju Kumar Bharathan; Unnikrishnan Gopalakrishnan; Dinesh Balakrishnan; O. V. Sudheer; Puneet Dhar; S. Sudhindran

Despite advances in the practice of living donor liver transplantation (LDLT), the optimum surgical approach with respect to the middle hepatic vein (MHV) in right lobe LDLT remains undefined. We designed a randomized trial to compare the early postoperative outcomes in recipients and donors between extended right lobe grafts (ERGs; transection plane was maintained to the left of MHV and division of MHV performed beyond the segment VIII vein) and modified right lobe grafts (MRGs; transection plane was maintained to the right of MHV; the segment V and VIII drainage was reconstructed using a conduit of recipient portal vein). Eligible patients (n = 86) were prospectively randomized into the ERG arm (n = 43) and the MRG arm (n = 43) at the beginning of donor hepatectomy. The primary endpoint considered in this equivalence trial was patency of the MHV or the reconstructed “neo‐MHV” in the recipient. The secondary endpoints included biochemical parameters, postoperative complications, mortality in recipients as well as donors and volume regeneration of remnant liver in donors, measured at 2 months. The patency of the MHV was comparable in the ERG and MRG arms (90.7% versus 81.4%; difference, 9.3%; 95% confidence interval [CI], –5.8 to 24.4; z score, 1.245; P = 0.21). Volume regeneration of the remnant liver in donors was significantly better in the MRG arm (111.3% versus 87.3%; mean difference, 24%; 95% CI, 14.6‐33.3; P < 0.001). The remaining secondary endpoints in donors and recipients were similar between the 2 arms. To conclude, MRG with reconstructed neo‐MHV has comparable patency to native MHV in ERG and confers equivalent graft outflow in the recipient. Furthermore, it allows better remnant liver regeneration in the donor at 2 months. Liver Transplantation 24 888–896 2018 AASLD.


Oral Oncology | 2018

Gastro-omental free flap for reconstruction of tongue defects

Sivakumar Vidhyadharan; Krishnakumar Thankappan; Ramu Janarthanan; Deepak Balasubramanian; Mohit Sharma; Jimmy Mathew; O. V. Sudheer; Subramania Iyer

OBJECTIVES The purpose of this paper is to report the technique and outcomes of the use of gastro-omental free flap reconstruction in glossectomy defects. MATERIALS AND METHODS This is a prospective case series of 9 patients of tongue squamous cell carcinoma, who underwent either subtotal or partial glossectomy and reconstruction with gastro-omental free flap. The flap anatomy, surgical technique and the outcomes including the swallowing and speech are presented. RESULTS Five patients underwent partial glossectomy and 4 had sub-total glossectomy. The median age was 43 years; and the median follow up was 11.4 months. Laparoscopic harvest was done in 8 patients. There was one flap loss. Seven patients underwent postoperative radiotherapy. Functional evaluation was done in 5 patients who were disease free. Four could tolerate soft diet orally, one patient was on liquid to pureed diet. Speech was intelligible in 4. None of the patients had any complications related to laparotomy or laparoscopy. CONCLUSION Gastro-omental flap provided a secretory mucosal surface and was beneficial in the saliva depleted patients post radiotherapy. The laparoscopic harvest of this flap has minimized donor site morbidity. One patient had a flap loss. Two patients reported superficial ulcerations on the surface, one of them had to undergo surgical debulking to correct it while the other healed with conservative measures. Speech and swallowing outcomes of the reconstructed tongue was good, especially in patients with partial glossectomy. The reconstructed gastric mucosal flaps tolerated the adjuvant radiation well.


Indian Journal of Gastroenterology | 2014

Gastrointestinal intramural hematoma-Analysis of clinical and radiological features for early differentiation from mesenteric ischemia

R. Subhash; G. Unnikrishnan; Dinesh Balakrishnan; O. V. Sudheer; Puneet Dhar; S. Sudhindran

IntroductionLong-term anticoagulation is associated with hemorrhage at various sites. Gastrointestinal intramural bleeds and hematomas (IMH) often mimic mesenteric ischemia (MI) due to similar clinical settings and imaging features, making early differentiation difficult.AimTo compare the demography, clinical features and imaging characteristics of patients presenting with IMH with those of MI, so as to help in evolving clinical and imaging guidelines to differentiate both early in the course of the disease.MethodsAll radiologically (contrast-enhanced computed tomogram [CT]) diagnosed cases of gastrointestinal IMH from the hospital database during the period between 2006 and 2012 were retrospectively analyzed. This data was compared with the clinical and imaging features of a group of surgically confirmed MI during the same period. Patients not on anticoagulation therapy at the time of presentation and those with incomplete clinical or radiological data were excluded from the study.ResultsThere were 16 patients in IMH group and 54 patients in MI group. Clinical features like overt rectal bleeding or melena, and prolonged prothrombin time-international normalized ratio (PT-INR) more than three, and CT features like proximal location in the bowel, increased bowel wall thickness, hyperdensity on plain scan (>40 Hounsfield units (HU)), and short segment bowel involvement were significantly associated with IMH. Visualization of embolus and absent mesenteric vasculature to a segment of intestine in CT was significantly associated with MI.ConclusionAttention to clinical features and early CT scan can aid in early differentiation of IMH from MI, facilitating appropriate intervention early in the course of disease.


Journal of clinical and experimental hepatology | 2011

26 BILIRUBIN AS A PREDICTOR OF EARLY MORTALITY AFTER LIVER TRANSPLANTATION

S Kalghatgi; S Vivek; U Dattaram; St Binoj; P Nitin; G Unnikrishnan; B Dinesh; O. V. Sudheer; D Puneet; N Subhalal; S. Sudhindran

Case Report: A 42-year-old male was admitted to our hospital with the diagnosis of alcohol-induced decompensated liver disease. He underwent deceased donor liver transplantation on 09.03.2011. Caval anastomosis was done by a piggy-back technique to the common cloaca of the recipient hepatic veins. After the reperfusion, the liver got congested and compressed the inferior vena cava (IVC) causing persistent hypotension. To relieve the hepatic outflow obstruction, side-to-side anastomosis between recipient IVC and donor IVC was done. Even after cavo-caval anastomosis, the hepatic outflow obstruction persisted. Lifting the liver anteriorly and slightly downward relieved the hepatic outflow obstruction which in turn relieved the IVC compression. Liver was then fixed to the anterior abdominal wall to maintain the position. Patient is on regular follow-up and doing well.


Journal of clinical and experimental hepatology | 2011

44 hepatic steatosis-quantification by non-enhanced ct scan.

U Dattaram; St Binoj; Puneet Dhar; O. V. Sudheer; G Unnikrishnan; R Menon; Dinesh Balakrishnan; S. Sudhindran

152


Journal of clinical and experimental hepatology | 2011

19 cost of immunosuppression using generic products after liver transplantation.

St Binoj; S Abubacker; R Menon; B Dinesh; G Unnikrishnan; O. V. Sudheer; Puneet Dhar; S. Sudhindran

142


Indian Journal of Gastroenterology | 2012

Cost and efficacy of immunosuppression using generic products following living donor liver transplantation in India

S. Sudhindran; Shameena Aboobacker; Ramachanndran N. Menon; G. Unnikrishnan; O. V. Sudheer; Puneet Dhar


Indian Journal of Gastroenterology | 2010

Revisiting the double-barreled wet colostomy for simultaneous urinary and fecal diversion—an Indian experience

Sudhir Sukumar; E. Sivanandam; H. Sanjay Bhat; Georgie Mathew; O. V. Sudheer; Puneet Dhar

Collaboration


Dive into the O. V. Sudheer's collaboration.

Top Co-Authors

Avatar

Puneet Dhar

Amrita Institute of Medical Sciences and Research Centre

View shared research outputs
Top Co-Authors

Avatar

S. Sudhindran

Amrita Institute of Medical Sciences and Research Centre

View shared research outputs
Top Co-Authors

Avatar

Dinesh Balakrishnan

Amrita Institute of Medical Sciences and Research Centre

View shared research outputs
Top Co-Authors

Avatar

G. Unnikrishnan

Amrita Institute of Medical Sciences and Research Centre

View shared research outputs
Top Co-Authors

Avatar

Unnikrishnan Gopalakrishnan

Amrita Institute of Medical Sciences and Research Centre

View shared research outputs
Top Co-Authors

Avatar

K.Y. Santosh Kumar

Amrita Institute of Medical Sciences and Research Centre

View shared research outputs
Top Co-Authors

Avatar

Christi Titus Varghese

Amrita Institute of Medical Sciences and Research Centre

View shared research outputs
Top Co-Authors

Avatar

J. Shaji Mathew

Amrita Institute of Medical Sciences and Research Centre

View shared research outputs
Top Co-Authors

Avatar

Riju Menon

Amrita Institute of Medical Sciences and Research Centre

View shared research outputs
Top Co-Authors

Avatar

S.A. Aneesh

Amrita Institute of Medical Sciences and Research Centre

View shared research outputs
Researchain Logo
Decentralizing Knowledge